NASDAQ: PHVS - Pharvaris B.V.

Yield per half year: +17.57%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Pharvaris B.V.

Extended chart Simple chart
Financial Markets by TradingView

About Pharvaris B.V.

Pharvaris B. V., клиническая биофармацевтическая компания, занимается открытием и разработкой методов лечения редких заболеваний. Компания разрабатывает PHA121, низкомолекулярный антагонист брадикинина В2-рецептора для лечения наследственного ангионевротического отека. Она работает в Нидерландах, Швейцарии и Соединенных Штатах. Компания была зарегистрирована в 2015 году и базируется в Лейдене, Нидерланды.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-02-05
ISIN NL00150005Y4
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета eur
Див.доход ао 0
Сайт https://pharvaris.com
Цена ао 17.8
Change price per day: -3% (19.32)
Change price per week: +2.07% (18.36)
Change price per month: -0.478% (18.83)
Change price per 3 month: -13.68% (21.71)
Change price per half year: +17.57% (15.94)
Change price per year: -37.74% (30.1)
Change price per 3 year: +8.76% (17.23)
Change price per 5 year: 0% (18.74)
Change price per 10 year: 0% (18.74)
Change price per year to date: -2.14% (19.15)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 2.37 6
P/E 0 0
EV/EBITDA -5.5 0
Total: 3

Efficiency

Title Value Grade
ROA, % -24.76 0
ROE, % -25.71 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0025 10
Total: 8.4

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 1111.76 10
Yield EPS, % 849.59 10
Total: 8
More

Institutions Volume Share, %
General Atlantic, L.P. 6156252 11.81
FMR, LLC 5192984 9.97
venBio Partners LLC 4919504 9.44
Foresite Capital Management IV, LLC 4038842 7.75
Bain Capital Life Sciences Investors, LLC 3904319 7.49
Viking Global Investors, L.P. 3656923 7.02
VR Adviser, LLC 3395606 6.52
Cormorant Asset Management, LP 1711460 3.28
Novo Holdings A/S 1539325 2.95
EcoR1 Capital, LLC 900000 1.73

ETF Share, % Profitability for 1 year, % Dividends, %
Virtus LifeSci Biotech Clinical Trials ETF 0.85314 63.04 0.33



Head Job title Payment Year of birth
Ms. Anna Nijdam M.Sc., R.A. Head of Strategic Finance & Principal Accounting Officer N/A 1981 (44 years)
Dr. Peng Lu M.D., Ph.D. Chief Medical Officer N/A 1978 (47 years)
Dr. Morgan Conn Ph.D. Chief Business Officer N/A 1969 (56 years)
Maryann Cimino Director of Corporate Relations N/A
Mr. Wim Souverijns Ph.D. Chief Commercial Officer N/A 1971 (54 years)
Dr. Anne A. Lesage Ph.D. Chief Early Development Officer N/A 1961 (64 years)
Mr. Berndt Axel Edvard Modig CPA, M.B.A. Co-Founder, CEO & Executive Director 541.59k 1959 (66 years)
Dr. Stefan Abele Ph.D. Chief Technology Operations Officer N/A 1970 (55 years)
Ms. Annick Deschoolmeester Chief Human Resources Officer N/A 1973 (52 years)
Mr. David W. Nassif J.D. CFO & Corporate Secretary 1954 (71 year)

Address: Netherlands, Leiden, Emmy Noetherweg 2 - open in Google maps, open in Yandex maps
Website: https://pharvaris.com